<table id="t2" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2 The Influence of Age, Liver and Kidney Function, on the Clearance and Terminal Half-life of Ketorolac Tromethamine (IM<sup>1</sup> and ORAL<sup>2</sup>) in Adult Populations
</caption>
<col align="left" span="1" width="25.382%"></col>
<col align="left" span="1" width="22.497%"></col>
<col align="left" span="1" width="10%"></col>
<col align="left" span="1" width="13.255%"></col>
<col align="left" span="1" width="1.771%"></col>
<col align="left" span="1" width="22.083%"></col>
<col align="left" span="1" width="14.127%"></col>
<tbody>
<tr>
<td></td>
<td>
<content stylecode="bold">Total Clearance [in L/h/kg]</content>
<content stylecode="bold">
<sup>3</sup>
</content>
</td>
<td>
<content stylecode="bold">Terminal Half-life [in hours]</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">Type of Subjects</content>
</td>
<td>
<content stylecode="bold">IM</content>
<br/>
<content stylecode="bold">Mean (range)</content>
</td>
<td>
<content stylecode="bold">ORAL</content>
<br/>
<content stylecode="bold">Mean (range)</content>
</td>
<td>
<content stylecode="bold">IM</content>
<br/>
<content stylecode="bold">Mean (range)</content>
</td>
<td>
<content stylecode="bold">ORAL</content>
<br/>
<content stylecode="bold">Mean (range)</content>
</td>
</tr>
<tr>
<td>Normal Subjects
</td>
<td>0.023
</td>
<td>0.025
</td>
<td>5.3
</td>
<td>5.3
</td>
</tr>
<tr>
<td>IM (n=54)<br/>mean age=32, range=18 to 60
</td>
<td>(0.010 to 0.046)
</td>
<td>(0.013 to 0.050)
</td>
<td>(3.5 to 9.2)
</td>
<td>(2.4 to 9.0)
</td>
</tr>
<tr>
<td>Oral (n=77)
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>mean age=32, range=20 to 60
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Healthy Elderly Subjects<br/>IM (n=13), Oral (n=12)<br/>mean age=72, range=65 to 78
</td>
<td>0.019<br/>(0.013 to 0.034)
</td>
<td>0.024<br/>(0.018 to 0.034)
</td>
<td>7.0<br/>(4.7 to 8.6)
</td>
<td>6.1<br/>(4.3 to 7.6)
</td>
</tr>
<tr>
<td>Patients with Hepatic Dysfunction<br/>IM and Oral (n=7)<br/>mean age=51, range=43 to 64
</td>
<td>0.029<br/>(0.013 to 0.066)
</td>
<td>0.033<br/>(0.019 to 0.051)
</td>
<td>5.4<br/>(2.2 to 6.9)
</td>
<td>4.5<br/>(1.6 to 7.6)
</td>
</tr>
<tr>
<td>Patients with Renal Impairment<br/>IM (n=25), Oral (n=9)<br/>serum creatinine=1.9 to 5.0 mg/dL<br/>mean age (IM)=54, range 35 to 71<br/>mean age (Oral)=57, range=39 to 70
</td>
<td>0.015<br/>(0.005 to 0.043)
</td>
<td>0.016<br/>(0.007 to 0.052)
</td>
<td>10.3<br/>(5.9 to 19.2)
</td>
<td>10.8<br/>(3.4 to 18.9)
</td>
</tr>
<tr>
<td>Renal Dialysis Patients<br/>IM and Oral (n=9)<br/>mean age=40, range=27 to 63
</td>
<td>0.016<br/>(0.003 to 0.036)
</td>
<td>----
</td>
<td>13.6<br/>(8.0 to 39.1)
</td>
<td>----
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>1</sup>Estimated from 30 mg single IM doses of ketorolac tromethamine
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>2</sup>Estimated from 10 mg single oral doses of ketorolac tromethamine
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>3</sup>Liters/hours/kilogram
</paragraph>
</td>
</tr>
</tbody>
</table>